Alcon showcased new contact lens and dry eye disease developments during the American Optometric Association (AOA) Meeting 2026, taking place June 17-20 in Phoenix, Arizona, with a focus on expanding fitting options for patients with astigmatism and advancing treatment approaches for dry eye disease.
The company announced expanded toric parameter availability across its Precision1, Precision7, and Total30 contact lens brands, extending astigmatism correction options across daily, weekly, and monthly replacement modalities. According to Alcon, the broader parameter ranges are intended to help eye care professionals fit a larger proportion of astigmatic patients while improving first-fit success and reducing the need for refits. Alcon said the expanded offerings are designed to provide practitioners with greater flexibility when managing a broader range of prescriptions and patient needs.
The company reported that, with the addition of expanded parameters for Total30 for Astigmatism, the portfolio will cover 99% of astigmatic eyes. Alcon also noted that Total30 for Astigmatism now offers the broadest readily accessible parameter availability among leading monthly replacement toric contact lens brands.
“In practice, a lack of parameter options can be a barrier to fitting some astigmatic patients in contact lenses,” said Torrey J. Carlson, OD, a multi-practice owner and founder of Dr. Torrey J. Carlson & Associates. “The expanded toric parameters will be instrumental in making it easier to find the right fit, streamline appointments, and ultimately help more patients fit in lenses.”
Alcon’s AOA presence will also feature educational programming related to Tryptyr (acoltremon ophthalmic solution) 0.003%, a TRPM8 receptor agonist indicated for the treatment of the signs and symptoms of dry eye disease. The therapy is designed to stimulate natural tear production through neuromodulation and represents a novel mechanism of action within the dry eye treatment landscape.
Attendees will have an opportunity to learn more about the science underlying the therapy, while Selina R. McGee, OD, and colleagues are scheduled to present findings from a proof-of-concept study evaluating lipid layer thickness in patients with evaporative dry eye disease.
In the contact lens category, Alcon will highlight continued adoption of Precision7, the company’s weekly replacement lens within its "WaterInnovations" portfolio. Introduced as a 1-week replacement option between daily disposable and monthly modalities, Precision7 incorporates the company’s Activ-Flo System, which combines embedded moisturizing agents with a replenishing agent designed to support lens surface hydration throughout the wear cycle.
In addition to product-focused activities, Alcon will host its "WaterInnovations Immersive Experience" at Booth #643. The interactive exhibit is designed to demonstrate the science behind the company’s contact lens technologies through visual and educational displays, with presentations scheduled throughout the meeting.
Attendees can also Alcon throughout AOA for educational sessions and sponsored events:
- Thursday June 18th | Global Medical Affairs Breakfast Symposium, Room 132AB, 8am – 9am MST, with Marc R. Bloomenstein, OD, FAAO (Moderator); Ada Noh, OD; and Kaleb Abbott, OD, MS, FAAO, FOWNS
- Thursday June 18th | Pharma Lunch Symposium, Room 132AB, 12pm – 1pm MST, with Dr. Josh Johnston, OD; Dr. Mila Ioussifova, OD; and Dr. Cory Lappin, OD
- Friday June 19th | Keep the Connection, Grow the Convenience: MARLO Best Practices - Para Idea Exchange, Room 211 AB, 8am – 9:30am MST, with Cotie Suter, Practice Solutions, Alcon+
- Friday June 19th | CL OD Lunch Symposium: Say Yes to More Possibilities in Astigmatism Correction, Room 132AB, 12pm – 1pm MST, with Dr. Melissa Barnett and Dr. Jason Compton
For more information on Alcon’s presence at Optometry’s Meeting 2026, including scientific presentations and on-site programming, visit www.myalcon.com/professional/events/alcon-at-aoa-2026/ or stop by Booth #617.
